Impact of Parenteral Nutrition Versus Fasting on Hepatic Bile Acid Production and Transport in a Rabbit Model of Prolonged Critical Illness

Background Cholestatic liver dysfunction frequently occurs during critical illness. Administration of parenteral nutrition (PN) is thought to aggravate this. Underlying mechanisms are not clear. Methods In a burn model of prolonged critical illness, rabbits were randomized to a nutritional strategy either accepting caloric deficits (fasted, n = 11) or covering caloric needs by PN (fed, n = 10). At baseline and after 7 days of critical illness, markers of hepatotoxicity, circulating bile acids, and the hepatobiliary transport system were studied. Results Fasted animals had lower circulating alanine aminotransferase/aspartate aminotransferase levels than did the fed animals at day 7. Compared with baseline values, fed animals displayed lower serum unconjugated cholic acid (CA) and deoxycholic acid (DCA) levels. Unconjugated DCA remained unaltered in fasted animals. Unconjugated lithocholic acid was increased comparably in all animals, whereas hyodeoxycholic acid was not altered. In contrast, fasting induced a shift from unconjugated CA and DCA to glyco-CA and glyco-DCA. Total bile acids did not correlate with the bile acid–producing enzyme CYP7A1, but with the basolateral efflux transporter MRP3. Fasting increased protein expression of the basolateral (MRP3) and the canalicular (BSEP) transporter, whereas the canalicular efflux pump MRP2 was suppressed. Gene expression levels of the nuclear receptor farnesoid X receptor were lower with fasting and correlated inversely with MRP3. The heterodimer partner of farnesoid X receptor, retinoid X receptor &agr;, was increased with fasting and correlated positively with MRP3. Conclusions During prolonged critical illness, withholding PN improved markers for hepatocyte injury and accentuated bile acid transport toward the blood. This suggests that the latter is an adaptive rather than a dysfunctional feedback to illness.

[1]  M. Trauner,et al.  Hypoxic liver injury and cholestasis in critically ill patients , 2013, Current opinion in critical care.

[2]  Jürgen Popp,et al.  Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis , 2012, PLoS medicine.

[3]  G. Van den Berghe,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Critical Illness Evokes Elevated Circulating Bile Acids Related to Altered Hepatic Transporter and Nuclear Receptor Expression , 2011 .

[4]  G. Van den Berghe,et al.  Early versus Late Parenteral Nutrition in Critically Ill Adults , 2011, The New England journal of medicine.

[5]  C. Madl,et al.  Impact of hypoxic hepatitis on mortality in the intensive care unit , 2011, Intensive Care Medicine.

[6]  G. Van den Berghe,et al.  The Impact of Resuscitated Fecal Peritonitis on the Expression of the Hepatic Bile Salt Transporters in a Porcine Model , 2010, Shock.

[7]  M. Trauner,et al.  Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. , 2010, Pharmacology & therapeutics.

[8]  G. Van den Berghe,et al.  Increasing intravenous glucose load in the presence of normoglycemia: Effect on outcome and metabolism in critically ill rabbits , 2010, Critical care medicine.

[9]  G. Van den Berghe,et al.  The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. , 2009, The Journal of clinical endocrinology and metabolism.

[10]  M. Grounds,et al.  ‘Liver function tests’ on the intensive care unit: a prospective, observational study , 2009, Intensive Care Medicine.

[11]  M. Downes,et al.  Hepatobiliary ABC transporters: physiology, regulation and implications for disease. , 2009, Frontiers in bioscience.

[12]  A. Bonet,et al.  Caloric intake and liver dysfunction in critically ill patients. , 2009, Current opinion in clinical nutrition and metabolic care.

[13]  B. M. Forman,et al.  Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo. , 2008, Molecular endocrinology.

[14]  A. Francavilla,et al.  Cholestasis induced by total parenteral nutrition. , 2008, Clinics in liver disease.

[15]  R. Shulman,et al.  Mechanisms of Disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis , 2007, Nature Clinical Practice Gastroenterology &Hepatology.

[16]  P. Metnitz,et al.  Incidence and prognosis of early hepatic dysfunction in critically ill patients—A prospective multicenter study , 2007, Critical care medicine.

[17]  M. Trauner,et al.  Mechanisms of Disease: mechanisms and clinical implications of cholestasis in sepsis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[18]  R. Evans,et al.  Benefit of farnesoid X receptor inhibition in obstructive cholestasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Trauner,et al.  Fxr−/− mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids Published, JLR Papers in Press, December 4, 2005. , 2006, Journal of Lipid Research.

[20]  M. Trauner,et al.  Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. , 2005, Journal of clinical gastroenterology.

[21]  D. Häussinger,et al.  Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS , 2004, Biological chemistry.

[22]  J. Boyer,et al.  Cholestatic syndromes. , 2004, Current opinion in gastroenterology.

[23]  G. Van den Berghe,et al.  Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.

[24]  G. Van den Berghe,et al.  Growth hormone modulation of the rat hepatic bile transporter system in endotoxin-induced cholestasis. , 2003, Endocrinology.

[25]  G. Van den Berghe,et al.  A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. , 2002, Endocrinology.

[26]  J. Boyer,et al.  Cellular localization and up‐regulation of multidrug resistance–associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver , 2001, Hepatology.